Clofabosin: Difference between revisions
| Line 430: | Line 430: | ||
{| class="bluetable lightbluebg" | {| class="bluetable lightbluebg" | ||
|- | |- | ||
! !! Indicative !! Subjunctive | ! !! Indicative !! Negative indicative !! Subjunctive !! Negative subjunctive | ||
|- | |- | ||
! Past | ! Past | ||
| ''-nazole'' || ''-nazumab'' | | ''-nazole'' || ''-flozole'' || ''-nazumab'' || ''-tuzumab'' | ||
|- | |- | ||
! Present | ! Present | ||
| ''-navir'' || ''-numab'' | | ''-navir'' || ''-flovir'' || ''-numab'' || ''-tumab'' | ||
|- | |- | ||
! Timeless | ! Timeless | ||
| ''-natinib'' || ''-navetmab'' | | ''-natinib'' || ''-flotinib'' || ''-navetmab'' || ''-tuvetmab'' | ||
|- | |- | ||
! Future | ! Future | ||
| ''-nercept'', ''-navircept'' || ''-naximab'' | | ''-nercept'', ''-navircept'' || ''-flocept'', ''-flovircept'' || ''-naximab'' || ''-tuximab'' | ||
|} | |} | ||